Clinical Trial Update: 12 Weeks Treatment With DDP225 or Placebo in Patients With Chronic Functional Vomiting [Phase 2]

View source ↗

Summary

A Phase 2 trial testing DDP225 versus placebo for chronic functional vomiting was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Functional Vomiting

Drugs mentioned

• DDP225

Snippet

Sponsor: Dynogen Pharmaceuticals | Conditions: Vomiting | Phase 2 | Status: TERMINATED